Skip to Content

Tag: AOM Infusion


News

In brief: AdaptHealth’s static revenue, bid program’s impact, AOM’s Western expansion 

November 6, 2024HME News Staff

PLYMOUTH MEETING, Pa. – AdaptHealth reported third quarter net revenue of $805.9 million compared to $804 million, an increase of 0.2% year over year.  Net income attributable to AdaptHealth was $22.9 million vs. a net loss of $454.1 million. Adjusted EBITDA was $164.3 million vs. $161.2 million, an increase of 1.9%  “I continue to be optimistic about the road ahead,” said Suzanne Foster, CEO. “We have identified growth opportunities, we are assembling a high...

AdaptHealth, AOM Infusion, Competitive Bidding, Financial Results, Home Infusion


Read Full Articlered right arrow icon

Also Noted

AOM strengthens presence out West 

November 5, 2024HME News Staff

ARLINGTON, Va. – AOM Infusion is expanding its presence in Arizona, Michigan and Washington. The company says it is committed to developing strong partnerships with local health care providers, health systems and payers across the Southwest, Pacific Northwest and Midwest. “We are really proud of the growth the company has experienced over the past year,” said Keyur Mehta, CEO of AOM Infusion. “Strengthening our presence in these regions and strategically adding ambulatory...

AOM Infusion, Home Infusion


Read Full Articlered right arrow icon

Also Noted

AOM names new CEO 

May 8, 2023HME News Staff

CHARLOTTE, N.C. – AOM Infusion, which provides home-based intravenous immunoglobulin IVIG therapy to patients with more than 80 different chronic conditions, has named Keyur Mehta as CEO. Christopher York will continue in his position as chairman of the company. “Keyur is an experienced specialty infusion executive and we have been impressed by his operational and team building capabilities,” said Petri Lindberg, Principal at Ridgemont Equity Partners, which bought AOM in 2022....

AOM Infusion, Home Infusion, Keyur Mehta


Read Full Articlered right arrow icon